Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Pharmaceuticals & Biotech
Create a narrative
Hansa Biopharma Community
OM:HNSA Community
1
Narratives
written by author
0
Comments
on narratives written by author
6
Fair Values set
on narratives written by author
Create a narrative
Hansa Biopharma
Latest
Undervalued
Overvalued
Community Investing Ideas
There are no community narratives available.
Your Valuation for
HNSA
HNSA
Hansa Biopharma
Your Fair Value
SEK
Current Price
SEK 24.20
62.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-845m
1b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 1.1b
Earnings SEK 206.9m
Advanced
Set Fair Value